DRUG STRATEGIES

EIN: 521837390 501(c)(3) Public & Societal Benefit

WASHINGTON, DC

Total Revenue
$3,639
Total Expenses
$358,403
Total Assets
$1,673,953
Net Assets
$1,659,182
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1993
Legal Domicile
CA
Principal Officer
MATHEA FALCO
Phone
4156386600
Tax Period
2024-07-01 to 2025-06-30

DRUG STRATEGIES, founded in 1993, is a micro nonprofit in the Public & Societal Benefit sector that reported $4K in total revenue in fiscal year 2024. Revenue fell 100% from the prior year — a significant decline worth monitoring. Expenses of $358K exceeded revenue, resulting in a 9749% operating deficit.

Mission

DRUG STRATEGIES PROMOTES MORE EFFECTIVE APPROACHES TO THE NATION'S DRUG PROBLEMS AND SUPPORTS PRIVATE AND PUBLIC EFFORTS TO REDUCE THE DEMAND FOR DRUGS THROUGH PREVENTION, EDUCATION AND TREATMENT.

Program Service Accomplishments

Program 1
Expenses: $293,267

DRUG STRATEGIES' PRIMARY FOCUS IS ON RESPONDING TO THE CURRENT OVERDOSE EPIDEMIC IN THE US, DRIVEN LARGELY BY THE OPIOID FENTANYL. IN 2024-2025, MORE THAN 100,000 DRUG OVERDOSE DEATHS WERE REPORTED...

Read more

DRUG STRATEGIES' PRIMARY FOCUS IS ON RESPONDING TO THE CURRENT OVERDOSE EPIDEMIC IN THE US, DRIVEN LARGELY BY THE OPIOID FENTANYL. IN 2024-2025, MORE THAN 100,000 DRUG OVERDOSE DEATHS WERE REPORTED, AND THE NUMBERS CONTINUE TO CLIMB. GREATER EFFORTS AT PREVENTION AND TREATMENT ARE URGENTLY NEEDED.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $250
Program Service Revenue $0
Investment Income $3,389
Other Revenue $0
TOTAL REVENUE $3,639

Expense Breakdown

Grants Paid $0
Salaries & Benefits $130,763
Fundraising Expenses $28,975
Program Expenses $293,267
Other Expenses $227,640
TOTAL EXPENSES $358,403

Year-over-Year Comparison

2024 2023 Change
Revenue $3,639 $1,867,462 -1.0%
Expenses $358,403 $375,191 0.0%
Net Income $-354,764 $1,492,271 -1.2%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
8
Independent Members
7
Employees
2
Volunteers
N/A

Governance Policies

✓ Conflict of Interest Policy
✓ Whistleblower Policy
✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$117,761
Total Directors
8
$117,761
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
MARIAN WRIGHT EDELMAN DIRECTOR 1.00
Director
$0 $0 $0
LOUISE BRYSON DIRECTOR 1.00
Director
$0 $0 $0
MORRIS PANNER DIRECTOR 1.00
Director
$0 $0 $0
MICHAEL KANTOR DIRECTOR 1.00
Director
$0 $0 $0
AMBASSADOR JAMES R JONES BOARD CHAIR 1.00
Officer Director
$0 $0 $0
MARNI VLIET DIRECTOR 1.00
Director
$0 $0 $0
DR A THOMAS MCLELLAN DIRECTOR 1.00
Director
$0 $0 $0
MATHEA FALCO EXECUTIVE DIR/PRESIDENT 40.00
Officer Director
$37,950 $79,811 $117,761
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $3,639 $358,403 $1,673,953 $-354,764
2024 $1,867,462 $375,191 $1,905,837 $1,492,271
2023 $73,344 $237,590 $365,764 $-164,246
2022 $182,093 $284,100 $462,658 $-102,007
2021 $118,239 $284,473 $772,173 $-166,234
2020 $192,630 $312,252 $733,871 $-119,622
2019 $156,286 $360,700 $843,669 $-204,414
Explore More Nonprofits
→Top 100 Nonprofits in District of Columbia →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare DRUG STRATEGIES with other nonprofits in District of Columbia and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.